Ensign Peak Advisors’s Theravance Biopharma TBPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-60,907
| Closed | -$573K | – | 1726 |
|
|
2024
Q4 | $573K | Hold |
60,907
| – | – | ﹤0.01% | 1557 |
|
|
2024
Q3 | $491K | Hold |
60,907
| – | – | ﹤0.01% | 1612 |
|
|
2024
Q2 | $516K | Hold |
60,907
| – | – | ﹤0.01% | 1592 |
|
|
2024
Q1 | $546K | Sell |
60,907
-3,073
| -5% | -$27.6K | ﹤0.01% | 1603 |
|
|
2023
Q4 | $719K | Hold |
63,980
| – | – | ﹤0.01% | 1550 |
|
|
2023
Q3 | $552K | Buy |
63,980
+7,250
| +13% | +$62.6K | ﹤0.01% | 1561 |
|
|
2023
Q2 | $587K | Hold |
56,730
| – | – | ﹤0.01% | 1586 |
|
|
2023
Q1 | $616K | Buy |
56,730
+9,150
| +19% | +$99.3K | ﹤0.01% | 1573 |
|
|
2022
Q4 | $534K | Buy |
47,580
+22,750
| +92% | +$255K | ﹤0.01% | 1603 |
|
|
2022
Q3 | $252K | Hold |
24,830
| – | – | ﹤0.01% | 1783 |
|
|
2022
Q2 | $225K | Hold |
24,830
| – | – | ﹤0.01% | 1757 |
|
|
2022
Q1 | $237K | Hold |
24,830
| – | – | ﹤0.01% | 1832 |
|
|
2021
Q4 | $274K | Buy |
+24,830
| New | +$274K | ﹤0.01% | 1842 |
|
|
2020
Q2 | – | Sell |
-6,081
| Closed | -$141K | – | 1698 |
|
|
2020
Q1 | $141K | Sell |
6,081
-6,081
| -50% | -$141K | ﹤0.01% | 1563 |
|
|
2019
Q4 | $315K | Buy |
+12,162
| New | +$315K | ﹤0.01% | 1586 |
|